对心律失常性右心室心肌病的管理
Sayed Al-Aidarous1, Alexandros Protonotarios1,2, Perry M Elliott1
1Institute of Cardiovascular Science, University College London, London, UK.
Heart (British Cardiac Society)
|July 11, 2023
概括
节律失调的右室心肌病 (ARVC) 治疗具有挑战性. 新兴的疗法,如结合的flekainide和bisoprolol,切除和放射治疗,显示出对管理心室节律失常和心脏突然死亡的承诺.
科学领域:
- 心脏病学 心脏病学
- 遗传学 遗传学 是一个
- 电子生理学 电子生理学
背景情况:
- 节律失调性右室心肌病变 (ARVC) 是一种遗传性心肌疾病.
- 它涉及心肌纤维脂肪的替代,导致心室节律失常和心脏突然死亡.
- 目前的治疗选择面临疾病复杂性和小患者队列的限制.
研究的目的:
- 审查目前和新兴的治疗策略来管理ARVC.
- 评估抗心律失常药物,切除和新型干预措施的证据基础.
- 讨论植入式心脏转换器-除器在ARVC管理中的作用.
主要方法:
- 对抗心律失常药物,射频剥离,立体辐射疗法和未来疗法的文献综述.
- 对ARVC治疗方法的临床试验数据和观察性研究的分析.
- 讨论当前和研究方法的有效性和局限性.
主要成果:
- 对于像β阻塞剂,索塔醇和阿米奥达龙这样的抗失常药物的证据有限或不一致.
- 结合的flekainide和bisoprolol可以提供更好的疗效.
- 射频切除,特别是结合的内心/表心方法,显示出有可能破坏心动脉回路.
- 立体辐射疗法是一种新兴的选择,其目标是超越痕修饰的分子途径.
- 植入式心脏转换器-除器至关重要,但存在风险.
结论:
- 由于治疗挑战,ARVC管理需要采用多方面的方法.
- 新的治疗策略,包括药物组合,切除和放射治疗,正在调查中.
- 仔细考虑风险和益处对于像ICD植入等干预措施至关重要.
更多相关视频
08:42Cox-Maze IV Procedure Concomitant with Valvular Surgery In Situs Inversus Dextrocardia: A Single-Center Experience in China
Published on: February 11, 2022
3.5K
07:41Insertion, Maintenance, and Removal of the Percutaneous Dual Lumen Cannula Right Ventricular Assist Device
Published on: July 20, 2022
1.9K
相关概念视频
01:29Cardiomyopathy IV: Restrictive Cardiomyopathy
12
Restrictive cardiomyopathy (RCM) is a rare heart muscle disease characterized by impaired ventricular filling due to stiffened ventricular walls, leading to significant diastolic dysfunction.EtiologyRestrictive cardiomyopathy can arise from both inherited and acquired diseases, many of which are systemic. It is categorized into four main types: infiltrative, storage, non-infiltrative, and endomyocardial diseases.Infiltrative diseases, such as amyloidosis, lead to RCM by depositing amyloid...
12
01:29Cardiomyopathy V: Interprofessional Care
17
Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
17
01:30Cardiomyopathy II: Dilated Cardiomyopathy
11
Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
11
01:29Cardiomyopathy VI: Nursing Management
13
Assessment: Nursing management of patients with cardiomyopathy begins with a thorough assessment of the patient's history, including a family history of cardiomyopathy or sudden cardiac death, personal history of heart disease, hypertension, diabetes, and any alcohol consumption or drug use.During the physical examination, assess vital signs, look for signs of heart failure (such as edema, jugular venous distention, and cyanosis), auscultate for abnormal heart sounds (like murmurs and gallops),...
13
01:29Cardiomyopathy III: Hypertrophic Cardiomyopathy
16
Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
16
01:25Dysrhythmias VI: Management of Dysrhythmias
19
Dysrhythmia management involves a multifaceted approach, incorporating pharmacological treatments, medical procedures, surgical interventions, lifestyle modifications, and patient education.Pharmacological ManagementAntiarrhythmic Drugs:Class I (Sodium Channel Blockers): This class includes quinidine and procainamide, which reduce the speed of impulse conduction in the heart, stabilize the cardiac membrane, and control arrhythmias. Quinidine and procainamide are Class IA agents that prolong the...
19